标题
Rituximab for the treatment of multiple sclerosis: a review
作者
关键词
-
出版物
JOURNAL OF NEUROLOGY
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-01-08
DOI
10.1007/s00415-020-10362-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Rituximab in multiple sclerosis at general hospital level
- (2020) Johan Hellgren et al. ACTA NEUROLOGICA SCANDINAVICA
- Cancer Risk for Fingolimod, Natalizumab, and Rituximab in MS Patients
- (2020) Peter Alping et al. ANNALS OF NEUROLOGY
- Post-rituximab immunoglobulin M (IgM) hypogammaglobulinemia
- (2020) Khalaf Kridin et al. AUTOIMMUNITY REVIEWS
- SARS‐CoV ‐2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad
- (2020) Sandra Amor et al. ANNALS OF NEUROLOGY
- Comparison of rituximab originator (MabThera®) to biosimilar (Truxima®) in patients with multiple sclerosis
- (2020) Thomas Perez et al. Multiple Sclerosis Journal
- ¿Es esperable que haya cuadros neurológicos por la pandemia por SARS-CoV-2?
- (2020) J. Matías-Guiu et al. NEUROLOGIA
- Immunology of COVID‐19: mechanisms, clinical outcome, diagnostics and perspectives – a report of the European Academy of Allergy and Clinical Immunology (EAACI)
- (2020) M Sokolowska et al. ALLERGY
- Persisting SARS‐CoV‐2 viraemia after rituximab therapy: two cases with fatal outcome and a review of the literature
- (2020) Phil‐Robin Tepasse et al. BRITISH JOURNAL OF HAEMATOLOGY
- COVID‐19 vaccine‐readiness for anti‐CD20‐depleting therapy in autoimmune diseases
- (2020) D. Baker et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Rituximab biosimilars in clinical practice
- (2020) Wojciech Jurczak et al. LEUKEMIA & LYMPHOMA
- Recovery from COVID-19 in a B-cell-depleted multiple sclerosis patient
- (2020) Hannah Wurm et al. Multiple Sclerosis Journal
- Late-onset neutropenia after RITUXIMAB therapy for multiple sclerosis, neuromyelitis optica spectrum disorders and MOG-antibody-associated diseases
- (2020) J. Rigal et al. Multiple Sclerosis and Related Disorders
- B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran
- (2020) Farinaz Safavi et al. Multiple Sclerosis and Related Disorders
- Anti-CD20 and COVID-19 in multiple sclerosis and related disorders: A case series of 60 patients from Madrid, Spain
- (2020) Paloma Montero-Escribano et al. Multiple Sclerosis and Related Disorders
- COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?
- (2020) Giovanni Novi et al. Multiple Sclerosis and Related Disorders
- Impact of coronavirus disease (COVID-19) pandemic on multiple sclerosis care
- (2020) Sara Salama et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis
- (2019) Justin M. Honce et al. NEUROLOGY
- Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis
- (2019) Hans Lassmann Frontiers in Immunology
- The Diversity of Encephalitogenic CD4+ T Cells in Multiple Sclerosis and Its Animal Models
- (2019) Benjamin Segal Journal of Clinical Medicine
- Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis
- (2019) M. Boremalm et al. EUROPEAN JOURNAL OF NEUROLOGY
- Efficacy and safety of rituximab for relapsing-remitting multiple sclerosis: A systematic review and meta-analysis
- (2019) Yang Hu et al. AUTOIMMUNITY REVIEWS
- Rituximab therapy for primary central nervous system vasculitis: A 6 patient experience and review of the literature
- (2019) Carlo Salvarani et al. AUTOIMMUNITY REVIEWS
- Pharmacoeconomics of synthetic therapies for multiple sclerosis
- (2019) Emanuele D’Amico et al. EXPERT OPINION ON PHARMACOTHERAPY
- Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy
- (2019) Fernando C. Fervenza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vaccination in Multiple Sclerosis: Friend or Foe?
- (2019) Tobias Zrzavy et al. Frontiers in Immunology
- Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders
- (2019) Celine Kaegi et al. Frontiers in Immunology
- Infection Risks Among Patients With Multiple Sclerosis Treated With Fingolimod, Natalizumab, Rituximab, and Injectable Therapies
- (2019) Gustavo Luna et al. JAMA Neurology
- Role of B cells and antibodies in multiple sclerosis
- (2019) Pitchaya Wanleenuwat et al. Multiple Sclerosis and Related Disorders
- B-cell Therapy for Multiple Sclerosis: Entering an era
- (2018) Ariele L. Greenfield et al. ANNALS OF NEUROLOGY
- Safety and Efficacy of Rituximab
- (2018) Brett Alldredge et al. CLINICAL NEUROPHARMACOLOGY
- Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
- (2018) Carmen Alcalá et al. JOURNAL OF NEUROLOGY
- Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
- (2018) Yasuo Oshima et al. Multiple Sclerosis Journal
- Efficacy of rituximab in refractory RRMS
- (2018) Pierre Durozard et al. Multiple Sclerosis Journal
- Reassessing B cell contributions in multiple sclerosis
- (2018) Rui Li et al. NATURE IMMUNOLOGY
- The national incidence of PML in Sweden, 1988–2013
- (2018) Ellen Iacobaeus et al. NEUROLOGY
- Effectiveness and safety of Rituximab in multiple sclerosis: an observational study from Southern Switzerland
- (2018) Barbara Scotti et al. PLoS One
- Long-term safety of rituximab induced peripheral B-cell depletion in autoimmune neurological diseases
- (2018) Anza B. Memon et al. PLoS One
- Predictors of hypogammaglobulinemia during rituximab maintenance therapy in rheumatoid arthritis: A 12-year longitudinal multi-center study
- (2018) G. Boleto et al. SEMINARS IN ARTHRITIS AND RHEUMATISM
- Comparative Effectiveness of Rituximab and Other Initial Treatment Choices for Multiple Sclerosis
- (2018) Mathias Granqvist et al. JAMA Neurology
- Drug-associated progressive multifocal leukoencephalopathy in multiple sclerosis patients
- (2018) Yasuo Oshima et al. Multiple Sclerosis Journal
- Efficacy of rituximab in refractory RRMS
- (2018) Pierre Durozard et al. Multiple Sclerosis Journal
- Memory B Cells Activate Brain-Homing, Autoreactive CD4+ T Cells in Multiple Sclerosis
- (2018) Ivan Jelcic et al. CELL
- Peripheral CD19+ B-cell counts and infusion intervals as a surrogate for long-term B-cell depleting therapy in multiple sclerosis and neuromyelitis optica/neuromyelitis optica spectrum disorders
- (2018) Gisa Ellrichmann et al. JOURNAL OF NEUROLOGY
- Safety and Efficacy of Rituximab in Multiple Sclerosis: A Retrospective Observational Study
- (2018) Bassem I. Yamout et al. Journal of Immunology Research
- Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience
- (2018) Emanuele D'Amico et al. Multiple Sclerosis and Related Disorders
- Multiple sclerosis
- (2018) Massimo Filippi et al. Nature Reviews Disease Primers
- Deciphering the Role of B Cells in Multiple Sclerosis—Towards Specific Targeting of Pathogenic Function
- (2017) Klaus Lehmann-Horn et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Age as a risk factor for early onset of natalizumab-related progressive multifocal leukoencephalopathy
- (2017) Luca Prosperini et al. JOURNAL OF NEUROVIROLOGY
- Efficacy and safety of rituximab in neuromyelitis optica: Review of evidence
- (2017) Omid Mirmosayyeb et al. Journal of Research in Medical Sciences
- Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study
- (2017) Marloes HJ Hagens et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Rituximab treatment of myasthenia gravis: A systematic review
- (2017) Rup Tandan et al. MUSCLE & NERVE
- Bracing for the biosimilar wave
- (2017) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Economics and Cost-Effectiveness of Multiple Sclerosis Therapies in the USA
- (2017) Daniel M. Hartung Neurotherapeutics
- Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis
- (2017) Jeffrey M. Gelfand et al. Neurotherapeutics
- Malignant Neoplasms in Patients With Rheumatoid Arthritis Treated With Tumor Necrosis Factor Inhibitors, Tocilizumab, Abatacept, or Rituximab in Clinical Practice
- (2017) Hjalmar Wadström et al. JAMA Internal Medicine
- Cerebral rituximab uptake in multiple sclerosis: A 89Zr-immunoPET pilot study
- (2017) Marloes HJ Hagens et al. Multiple Sclerosis Journal
- Rituximab in multiple sclerosis: Frequency and clinical relevance of anti-drug antibodies
- (2017) Nicky Dunn et al. Multiple Sclerosis Journal
- Rituximab biosimilar and reference rituximab in patients with previously untreated advanced follicular lymphoma (ASSIST-FL): primary results from a confirmatory phase 3, double-blind, randomised, controlled study
- (2017) Wojciech Jurczak et al. Lancet Haematology
- Memory B Cells are Major Targets for Effective Immunotherapy in Relapsing Multiple Sclerosis
- (2017) David Baker et al. EBioMedicine
- Rituximab versus fingolimod after natalizumab in multiple sclerosis patients
- (2016) Peter Alping et al. ANNALS OF NEUROLOGY
- A multicentre randomised controlled trial to compare the pharmacokinetics, efficacy and safety of CT-P10 and innovator rituximab in patients with rheumatoid arthritis
- (2016) Dae Hyun Yoo et al. ANNALS OF THE RHEUMATIC DISEASES
- Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
- (2016) Tomas Olsson et al. Nature Reviews Neurology
- Reduced inflammation in relapsing-remitting multiple sclerosis after therapy switch to rituximab
- (2016) Pierre de Flon et al. NEUROLOGY
- Rituximab in multiple sclerosis
- (2016) Jonatan Salzer et al. NEUROLOGY
- Therapeutic Advances and Future Prospects in Progressive Forms of Multiple Sclerosis
- (2016) Afsaneh Shirani et al. Neurotherapeutics
- Efficacy and Safety of Rituximab Therapy in Neuromyelitis Optica Spectrum Disorders
- (2016) Valentina Damato et al. JAMA Neurology
- The effects of intrathecal rituximab on biomarkers in multiple sclerosis
- (2016) Joanne Topping et al. Multiple Sclerosis and Related Disorders
- Insufficient disease inhibition by intrathecal rituximab in progressive multiple sclerosis
- (2016) Mika Komori et al. Annals of Clinical and Translational Neurology
- Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis: 2-year results of a randomised trial
- (2015) Rachel B Jones et al. ANNALS OF THE RHEUMATIC DISEASES
- Clinical Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies Approved to Treat Rheumatoid Arthritis
- (2015) David Ternant et al. CLINICAL PHARMACOKINETICS
- Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: Just the tip of the iceberg?
- (2015) Adrian M. Di Bisceglie et al. HEPATOLOGY
- Randomized Controlled Trial of Rituximab in Patients With Graves' Orbitopathy
- (2015) Marius N. Stan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID)
- (2015) P. S. Rommer et al. Journal of Neuroimmune Pharmacology
- Rituximab in paediatric onset multiple sclerosis: a case series
- (2015) Jonatan Salzer et al. JOURNAL OF NEUROLOGY
- Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy
- (2015) Rui Li et al. Science Translational Medicine
- An update on immunopathogenesis, diagnosis, and treatment of multiple sclerosis
- (2015) Neeta Garg et al. Brain and Behavior
- Risk factors for severe bacterial infections in patients with systemic autoimmune diseases receiving rituximab
- (2014) Marion Heusele et al. CLINICAL RHEUMATOLOGY
- Hepatitis B Reactivation in Patients With Previous Hepatitis B Virus Exposure Undergoing Rituximab-Containing Chemotherapy for Lymphoma: A Prospective Study
- (2014) Wai-Kay Seto et al. JOURNAL OF CLINICAL ONCOLOGY
- Rituximab Efficiently Depletes Increased CD20-Expressing T Cells in Multiple Sclerosis Patients
- (2014) Arumugam Palanichamy et al. JOURNAL OF IMMUNOLOGY
- Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis
- (2014) Valeria Studer et al. JOURNAL OF NEUROIMMUNOLOGY
- Efficacy and safety of rituximab for myasthenia gravis: a systematic review and meta-analysis
- (2014) Raffaele Iorio et al. JOURNAL OF NEUROLOGY
- Decreased Dicer expression is linked to increased expression of co-stimulatory molecule CD80 on B cells in multiple sclerosis
- (2014) Latt Latt Aung et al. Multiple Sclerosis Journal
- Treatment of primary CNS vasculitis with rituximab: Case report
- (2014) C. Salvarani et al. NEUROLOGY
- B cells in MS and NMO: pathogenesis and therapy
- (2014) Markus Krumbholz et al. Seminars in Immunopathology
- The Effect of Glatiramer Acetate Therapy on Functional Properties of B Cells From Patients With Relapsing-Remitting Multiple Sclerosis
- (2014) Sara J. Ireland et al. JAMA Neurology
- In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses
- (2013) Jaishree Bankoti et al. ANNALS OF NEUROLOGY
- Physicochemical and Functional Comparability Between the Proposed Biosimilar Rituximab GP2013 and Originator Rituximab
- (2013) Jan Visser et al. BIODRUGS
- The effect of rituximab on vaccine responses in patients with immune thrombocytopenia
- (2013) I. Nazi et al. BLOOD
- Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study
- (2013) Maarten J Titulaer et al. LANCET NEUROLOGY
- Epitope interactions of monoclonal antibodies targeting CD20 and their relationship to functional properties
- (2013) Christian Klein et al. mAbs
- Prolonged B-Cell Depletion in MuSK Myasthenia Gravis Following Rituximab Treatment
- (2013) John S. Yi et al. MUSCLE & NERVE
- Responsiveness to reduced dosage of rituximab in Chinese patients with neuromyelitis optica
- (2013) C.-S. Yang et al. NEUROLOGY
- Rituximab for the treatment of rheumatoid arthritis: an update
- (2013) Chi Chiu Mok Drug Design Development and Therapy
- Effects of rituximab on lymphocytes in multiple sclerosis and neuromyelitis optica
- (2013) Jennifer Graves et al. Multiple Sclerosis and Related Disorders
- Prevention and handling of acute allergic and infusion reactions in oncology
- (2012) M. Joerger ANNALS OF ONCOLOGY
- Rituximab in the treatment of refractory adult and juvenile dermatomyositis and adult polymyositis: A randomized, placebo-phase trial
- (2012) Chester V. Oddis et al. ARTHRITIS AND RHEUMATISM
- Functional identification of pathogenic autoantibody responses in patients with multiple sclerosis
- (2012) Christina Elliott et al. BRAIN
- Safety of rituximab in rheumatoid arthritis: A long-term prospective single-center study of gammaglobulin concentrations and infections
- (2012) Anne Isvy et al. JOINT BONE SPINE
- Novel cerebrospinal fluid and serum autoantibody targets for clinically isolated syndrome
- (2012) Myrthe Rouwette et al. JOURNAL OF NEUROCHEMISTRY
- Secretory products of multiple sclerosis B cells are cytotoxic to oligodendroglia in vitro
- (2012) Robert P. Lisak et al. JOURNAL OF NEUROIMMUNOLOGY
- Late-onset neutropenia following primary treatment of diff use large B-cell lymphoma with rituximab-containing therapy
- (2012) Samo Rozman et al. LEUKEMIA & LYMPHOMA
- B cells and antibodies in multiple sclerosis pathogenesis and therapy
- (2012) Markus Krumbholz et al. Nature Reviews Neurology
- Long-lasting treatment effect of rituximab in MuSK myasthenia
- (2012) J. Diaz-Manera et al. NEUROLOGY
- The evidence for a role of B cells in multiple sclerosis
- (2012) G. Disanto et al. NEUROLOGY
- Epstein-Barr Virus in Systemic Lupus Erythematosus, Rheumatoid Arthritis and Multiple Sclerosis—Association and Causation
- (2012) Andreas Lossius et al. Viruses-Basel
- Multiple Sclerosis: New Insights in Pathogenesis and Novel Therapeutics
- (2011) Daniel Ontaneda et al. Annual Review of Medicine
- Repeated Treatment With Rituximab Based on the Assessment of Peripheral Circulating Memory B Cells in Patients With Relapsing Neuromyelitis Optica Over 2 Years
- (2011) Su-Hyun Kim ARCHIVES OF NEUROLOGY
- Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis
- (2011) David B. Clifford ARCHIVES OF NEUROLOGY
- Rituximab blocks protective serologic response to influenza A (H1N1) 2009 vaccination in lymphoma patients during or within 6 months after treatment
- (2011) O. E. Yri et al. BLOOD
- Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis
- (2011) Laura Lovato et al. BRAIN
- Related B cell clones that populate the CSF and CNS of patients with multiple sclerosis produce CSF immunoglobulin
- (2011) Birgit Obermeier et al. JOURNAL OF NEUROIMMUNOLOGY
- Maximally tolerated versus minimally effective dose: the case of rituximab in multiple sclerosis
- (2011) A Scott Nielsen et al. Multiple Sclerosis Journal
- Safety and clinical outcomes of rituximab therapy in patients with different autoimmune diseases: experience from a national registry (GRAID)
- (2011) Hans-Peter Tony et al. ARTHRITIS RESEARCH & THERAPY
- Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms
- (2011) Daniel Tesfa et al. Expert Review of Hematology
- Results of a phase I/II study of ocrelizumab, a fully humanized anti-CD20 mAb, in patients with relapsed/refractory follicular lymphoma
- (2010) F. Morschhauser et al. ANNALS OF ONCOLOGY
- Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
- (2010) Laura Piccio et al. ARCHIVES OF NEUROLOGY
- Risk factors for severe infections in patients with rheumatoid arthritis treated with rituximab in the autoimmunity and rituximab registry
- (2010) J.-E. Gottenberg et al. ARTHRITIS AND RHEUMATISM
- New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
- (2010) Tadeusz Robak et al. BIODRUGS
- Incidence of Infusion-Associated Reactions with Rituximab for Treating Multiple Sclerosis
- (2010) Brandon A. Brown et al. DRUG SAFETY
- Rituximab in patients with chronic inflammatory demyelinating polyradiculoneuropathy: a report of 13 cases and review of the literature
- (2010) L. Benedetti et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Efficacy and Safety of Retreatment in Patients with Rheumatoid Arthritis with Previous Inadequate Response to Tumor Necrosis Factor Inhibitors: Results from the SUNRISE Trial
- (2010) P. J. MEASE et al. JOURNAL OF RHEUMATOLOGY
- Rituximab add-on therapy for breakthrough relapsing multiple sclerosis: A 52-week phase II trial
- (2010) R. T. Naismith et al. NEUROLOGY
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab-Associated Infections
- (2010) Juan C. Gea-Banacloche SEMINARS IN HEMATOLOGY
- Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
- (2009) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Rituximab in patients with primary progressive multiple sclerosis: Results of a randomized double-blind placebo-controlled multicenter trial
- (2009) Kathleen Hawker et al. ANNALS OF NEUROLOGY
- Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
- (2009) K. R. Carson et al. BLOOD
- Binding of Submaximal C1q Promotes Complement-Dependent Cytotoxicity (CDC) of B Cells Opsonized with Anti-CD20 mAbs Ofatumumab (OFA) or Rituximab (RTX): Considerably Higher Levels of CDC Are Induced by OFA than by RTX
- (2009) A. W. Pawluczkowycz et al. JOURNAL OF IMMUNOLOGY
- Reactivation of chronic hepatitis B virus infection following rituximab administration for rheumatoid arthritis
- (2009) Athina Pyrpasopoulou et al. RHEUMATOLOGY INTERNATIONAL
- Rituximab in relapsing-remitting multiple sclerosis: A 72-week, open-label, phase I trial
- (2008) Amit Bar-Or et al. ANNALS OF NEUROLOGY
- Clinical outcome and B cell depletion in patients with rheumatoid arthritis receiving rituximab monotherapy in comparison with patients receiving concomitant methotrexate
- (2008) K Owczarczyk et al. ANNALS OF THE RHEUMATIC DISEASES
- A longitudinal analysis of SLE patients treated with rituximab (anti-CD20): Factors associated with B lymphocyte recovery
- (2008) Jennifer A. Sutter et al. CLINICAL IMMUNOLOGY
- Increased incidence of interstitial pneumonia by CHOP combined with rituximab
- (2008) Daisuke Ennishi et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Rituximab levels in cerebrospinal fluid of patients with neurological autoimmune disorders
- (2008) HF Petereit et al. Multiple Sclerosis Journal
- B-Cell Depletion with Rituximab in Relapsing–Remitting Multiple Sclerosis
- (2008) Stephen L. Hauser et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started